Connect with us

Cannabis News

Constellation Brands Predicts Losing Over $50 Million Towards Its Canopy Growth Investment



  • Canopy Growth will likely not turn a profit for up to five years.
  • Constellation Brands experienced a loss of $1.30 per share last quarter.

Canopy Growth, an investment company in the cannabis industry, has been featured in many news stories lately for their acquisitions, sales, and new launches. While their success is a major moment for the cannabis industry, Constellation Brands isn’t happy at all about how long these changes will take to bring in revenue. In fact, even with all of these innovations and the growing cannabis market, the company expects to lose $54.8 million in this quarter alone.

Chief Executive Officer Mark Zekulin of Canopy recently spoke to investors, letting them know that their company may not turn a profit for another three to five years. As Constellation Brands holds nearly a 56% stake in Canopy, this delay will likely reflect millions of dollars lost by the time the company submits their regulatory filing.

Early this summer, executives from Constellation said that they were unhappy with the losses that Canopy has sustained. Interestingly enough, Canopy opted to fire co-CEO Bruce Linton fairly soon after.

During the first quarter, Constellation reported a $1.30 loss per share, while a profit of $3.77 per share was reported a year ago. The current loss appeared to be due to a $0.20 loss per share in connection with Canopy Growth.

Pouline Ireri lives in Kenya and is new at TOC but plans to contribute much more in the near future. She graduated from the University of Nairobi and is a Business consultant/Micro Finance specialist. Her affinity for cannabis and CBD came naturally through her own use and become an advocate based on the positive effects and results she experienced.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.